AQP3 and rosacea: Tang and colleagues showed that a TXA‐loaded ZIF‐8 presented a higher penetration capacity, based on the activation of the aquaporin‐3 protein (AQP‐3), and a significant improvement of the clinical signs of rosacea and melasma [45].